Laura Baumann
Clinical FellowAbout
Research
Publications
2025
Changes in Colorectal Cancer Screening Modalities Among Insured Individuals
Siddique S, Wang R, May F, Baum L, Gross C, Ma X. Changes in Colorectal Cancer Screening Modalities Among Insured Individuals. JAMA Network Open 2025, 8: e2538578. PMID: 41118161, PMCID: PMC12541536, DOI: 10.1001/jamanetworkopen.2025.38578.Peer-Reviewed Original ResearchConceptsFecal immunochemical testStool DNA testColorectal cancer screening modalitiesSocioeconomic statusScreening modalitiesMetropolitan area residentsRetrospective cohort studyDynamic cohortArea-level socioeconomic statusColorectal cancerMarkers of socioeconomic statusCohort studyTest useArea residentsAverage-risk individualsCancer screening modalitiesDNA testingImmunochemical testCOVID-19 pandemicSociodemographic groupsMain OutcomesClaims dataColonoscopyCOVID-19ResidentsOpioid prescribing trends and pain scores among adult patients with cancer in a large health system
Baum L, Soulos P, Kc M, Jeffery M, Ruddy K, Lerro C, Lee H, Graham D, Rivera D, Liberatore M, Leapman M, Jairam V, Dinan M, Gross C, Park H. Opioid prescribing trends and pain scores among adult patients with cancer in a large health system. Cancer 2025, 131: e70027. PMID: 40977160, PMCID: PMC12451255, DOI: 10.1002/cncr.70027.Peer-Reviewed Original ResearchConceptsOpioid prescribingMetastatic cancerNo painHealth systemPain scoresWidespread policy changeOpioid-naive adultsNewly diagnosed cancerOpioid-related harmsOpioid prescribing trendsPain managementOpioid prescriptionsRetrospective studyAdult patientsClinical strataPrescribingPrescribing trendsSurgical patientsLogistic regressionOpioidPainPatientsCancerStewardship policiesPolicy changesTemporal Trends in Opioid Use and Associated Outcomes for Patients Living with Advanced Cancer
Jairam V, Lindsay M, Soulos P, Gross C, Prsic E, Baum L, Park H. Temporal Trends in Opioid Use and Associated Outcomes for Patients Living with Advanced Cancer. Journal Of Pain And Symptom Management 2025, 70: 230-238.e7. PMID: 40403779, DOI: 10.1016/j.jpainsymman.2025.05.007.Peer-Reviewed Original ResearchPain-related ED visitsOpioid useGabapentinoid useOpioid-related encountersAdvanced cancerOpioid prescribingED visitsAdvanced solid tumor cancersEnd Results (SEER)-Medicare databaseHigh-risk opioid useNonopioid pain medicationsMultivariate logistic regression modelNon-cancer patientsSolid tumor cancersPain controlPain medicationInvestigate time trendsIndex dateLogistic regression modelsCancer cohortOpioidNoncancer patientsOpioid epidemicPatientsNoncancer cohortPsychedelics for Cancer Pain and Associated Psychological Distress: A Narrative Review of a Potential Strategy
Belitzky E, Carvalho L, Taylor M, Ortiz C, Baum L, Fiellin D, Lustberg M. Psychedelics for Cancer Pain and Associated Psychological Distress: A Narrative Review of a Potential Strategy. Cancer Medicine 2025, 14: e70586. PMID: 40052631, PMCID: PMC11886891, DOI: 10.1002/cam4.70586.Peer-Reviewed Original ResearchConceptsManagement of cancer painPsychological distressCancer painSymptom burdenUndertreatment of cancer painLevels of psychological distressFear of recurrenceSymptoms of cancerAssociated symptom burdenImprove pain managementMitigate psychological distressQuality of life challengesCancer-related painMitigate painAssociated psychological distressTreatment of cancer painNon-pharmacological approachesDiagnosis of cancerEfficacy of psychedelicsFear of deathLevel of evidenceCurrent level of evidenceBehavioral counselingCancer populationPain management
2024
Between ‘NET’ and ‘CoGNET’: A biphasic Neuroendocrine-Gangliocytic tumor of the pancreas
Khandakar B, Ng M, Baum L, Robert M. Between ‘NET’ and ‘CoGNET’: A biphasic Neuroendocrine-Gangliocytic tumor of the pancreas. Human Pathology Reports 2024, 38: 300763. DOI: 10.1016/j.hpr.2024.300763.Peer-Reviewed Original ResearchNeuroendocrine tumorsLow-grade neuroendocrine tumorHead of pancreasNerve sheath tumorsClinico-pathological findingsPancreatic headSheath tumorsImmunohistochemical profilePeriampullary regionCase reportDifferential diagnosisGangliocytic paragangliomaTumorGangliocytic differentiationPancreasTumor classificationParagangliomaUsing a Bayesian analytic approach to identify county-level ecological factors associated with survival among individuals with early-onset colorectal cancer
Siddique S, Baum L, Deziel N, Kelly J, Warren J, Ma X. Using a Bayesian analytic approach to identify county-level ecological factors associated with survival among individuals with early-onset colorectal cancer. PLOS ONE 2024, 19: e0311540. PMID: 39471191, PMCID: PMC11521299, DOI: 10.1371/journal.pone.0311540.Peer-Reviewed Original ResearchConceptsAge-of-onset colorectal cancerEarly-onset colorectal cancerEnd Results program dataCenters for Disease Control and Prevention dataCounty-level factorsColorectal cancerHealth risk behaviorsIdentified principal componentsOdds of survivalPreventive servicesSurvival disparitiesLinear mixed modelsEOCRCChronic diseasesPreventive factorsUS countiesSalt Lake CountyCA residentsRisk behaviorsUnited StatesProgram dataCounty-levelOlder ageBayesian analytical approachYounger ageImproving the detection and documentation of patients’ symptoms in an integrated gastrointestinal oncology and palliative care clinic.
Rao V, Trexler S, Boaz C, Phillips D, Baum L. Improving the detection and documentation of patients’ symptoms in an integrated gastrointestinal oncology and palliative care clinic. Journal Of Clinical Oncology 2024, 20: 336-336. DOI: 10.1200/op.2024.20.10_suppl.336.Peer-Reviewed Original ResearchEdmonton Symptom Assessment ScaleSymptom assessment toolsSymptom documentationIntegrated clinicPatient distressPalliative careAssessment toolDocumentation ratesResponse to patient distressInterdisciplinary palliative care teamIn-personSatisfaction surveyPalliative care teamPalliative care clinicMedian ratePatient-clinician communicationSymptom Assessment ScalePost-intervention dataPatient satisfaction surveyPost-intervention periodDocumentation of symptomsManual chart reviewPre-intervention baseline dataTreatment side effectsPC physiciansCharacterization of time toxicity in older patients with metastatic breast cancer
Atre S, Soulos P, Kuderer N, Gross C, Baum L, Dinan M, Lustberg M. Characterization of time toxicity in older patients with metastatic breast cancer. Breast Cancer Research And Treatment 2024, 207: 541-550. PMID: 38816556, DOI: 10.1007/s10549-024-07379-7.Peer-Reviewed Original ResearchMetastatic breast cancerBone-modifying agentsComorbid medical conditionsOlder patientsBreast cancerRetrospective cohort studySEER-Medicare databaseTreatment typeCancer treatment modalityTreatment modalitiesSEER-MedicareCohort studyUnadjusted analysisPatientsAge-related impactCancer treatmentComorbiditiesDay patientsCancerRadiotherapyOlder ageMedical conditionsToxicityTreatmentSociodemographic factorsOpioid prescribing trends and pain scores among adult patients with cancer in a large health system.
Baum L, Soulos P, KC M, Jeffery M, Ruddy K, Lerro C, Lee H, Graham D, Liberatore M, Rivera D, Leapman M, Jairam V, Dinan M, Gross C, Park H. Opioid prescribing trends and pain scores among adult patients with cancer in a large health system. Journal Of Clinical Oncology 2024, 42: 11059-11059. DOI: 10.1200/jco.2024.42.16_suppl.11059.Peer-Reviewed Original ResearchDocumented painHealth systemOpioid prescribingOpioid prescriptionsOpioid prescribing trendsYale New Haven Health SystemPrescribing trendsMetastatic cancerDocumented pain scoresUS health systemOpioid usePain scoresAdult patientsCalculated predicted probabilitiesFlowsheet dataRetrospective cohort studyRelated harmSolid tumor malignanciesCohort studyCancer painPrescribingContext of cancer treatmentStudy criteriaPainSurgery cohort
2023
Trends in new and persistent opioid use in older adults with and without cancer
Baum L, KC M, Soulos P, Jeffery M, Ruddy K, Lerro C, Lee H, Graham D, Rivera D, Leapman M, Jairam V, Dinan M, Gross C, Park H. Trends in new and persistent opioid use in older adults with and without cancer. Journal Of The National Cancer Institute 2023, 116: 316-323. PMID: 37802882, DOI: 10.1093/jnci/djad206.Peer-Reviewed Original ResearchAdditional opioid useNew opioid useOpioid useNon-metastatic cancerPersistent opioid useRetrospective cohort studySolid tumor malignanciesClinical strataEligible patientsNaïve patientsOpioid prescribingMetastatic patientsSurgery patientsCohort studySEER-MedicareMetastatic cancerPatientsTumor malignancyCancerOlder adultsSurgeryRandom sampleAdditional useChemotherapyPrescribing
Get In Touch
Contacts
Academic Office Number